Zacks: Digirad Corp. (DRAD) Receives Consensus Rating of “Strong Buy” from Analysts
Shares of Digirad Corp. (NASDAQ:DRAD) have received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Brokers have set a 12-month consensus price target of $7.00 for the company and are anticipating that the company will post $0.08 EPS for the current quarter, according to Zacks. Zacks has also assigned Digirad Corp. an industry rank of 112 out of 265 based on the ratings given to its competitors.
Several analysts have recently weighed in on the stock. B. Riley reiterated a “buy” rating and set a $7.00 target price on shares of Digirad Corp. in a research report on Sunday, September 11th. Zacks Investment Research upgraded shares of Digirad Corp. from a “sell” rating to a “hold” rating in a research report on Wednesday, August 17th.
In related news, Director Jeffrey E. Eberwein bought 28,482 shares of the company’s stock in a transaction on Friday, August 19th. The stock was bought at an average cost of $5.00 per share, with a total value of $142,410.00. Following the completion of the purchase, the director now owns 12,500 shares in the company, valued at approximately $62,500. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Jeffrey E. Eberwein bought 5,625 shares of the company’s stock in a transaction on Wednesday, September 14th. The stock was bought at an average cost of $5.00 per share, with a total value of $28,125.00. The disclosure for this purchase can be found here. 11.50% of the stock is currently owned by company insiders.
Several institutional investors have recently made changes to their positions in DRAD. JPMorgan Chase & Co. increased its position in shares of Digirad Corp. by 437.2% in the second quarter. JPMorgan Chase & Co. now owns 19,340 shares of the company’s stock worth $100,000 after buying an additional 15,740 shares in the last quarter. O Shaughnessy Asset Management LLC increased its position in shares of Digirad Corp. by 289.4% in the second quarter. O Shaughnessy Asset Management LLC now owns 19,559 shares of the company’s stock worth $101,000 after buying an additional 14,536 shares in the last quarter. AXA bought a new position in shares of Digirad Corp. during the second quarter worth $194,000. Hillsdale Investment Management Inc. increased its position in shares of Digirad Corp. by 11.9% in the second quarter. Hillsdale Investment Management Inc. now owns 75,280 shares of the company’s stock worth $388,000 after buying an additional 8,000 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Digirad Corp. by 13.3% in the second quarter. Bank of New York Mellon Corp now owns 81,374 shares of the company’s stock worth $418,000 after buying an additional 9,568 shares in the last quarter. 60.63% of the stock is owned by institutional investors.
Digirad Corp. (NASDAQ:DRAD) opened at 5.01 on Friday. Digirad Corp. has a 1-year low of $4.20 and a 1-year high of $6.92. The firm has a market cap of $98.04 million, a price-to-earnings ratio of 3.07 and a beta of 1.37. The company’s 50 day moving average is $5.07 and its 200-day moving average is $5.26.
Digirad Corp. (NASDAQ:DRAD) last issued its earnings results on Thursday, July 28th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. Digirad Corp. had a net margin of 34.22% and a return on equity of 10.03%. On average, analysts predict that Digirad Corp. will post $0.31 EPS for the current fiscal year.
Digirad Corp. Company Profile
Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Digirad Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad Corp. and related companies with MarketBeat.com's FREE daily email newsletter.